High dose Upadacitinib produces added advantage in moderate to severe atopic dermatitis Hina Zahid13 Dec 2021 9:00 AM ISTUpadacinib is a new drug for the treatment of adults and adolescents aged 12 years and older with moderate to severe atopic dermatitis who are...
Topical tacrolimus as effective as corticosteroids for atopic dermatitis in kids: Study MD Editorial Team3 Dec 2021 9:00 AM ISTFinland: A new study conducted by A. Salava and team noted that the application of tacrolimus 0.03% and 0.1% ointments and topical corticosteroids...
Pre-pregnancy obesity might increase atopic dermatitis risk among infants: Study Dr. Shravani Dali29 Nov 2021 9:00 AM ISTA new investigation from China published in the Pediatric Allergy and Immunology suggested that maternal pre-pregnancy overweight and obesity could...
Nemolizumab plus topical agents effective against atopic dermatitis and pruritus in children: Study MD Editorial Team26 Nov 2021 9:00 AM ISTJapan: Nemolizumab 60 mg Q4W given along with topical treatments in atopic dermatitis (AD) patients with inadequately controlled moderate-to-severe...
Atopic dermatitis linked with short stature and obesity in children: JAMA MD Editorial Team25 Nov 2021 10:00 AM ISTCanada: Mathew N. Nicholas and colleagues conducted a new study that found atopic dermatitis to be linked with shorter stature, higher BMI, and lower...
Tralokinumab associated with increased risk of conjunctivitis in severe AD: study Dr. Shravani Dali16 Nov 2021 9:00 AM ISTTreatment with tralokinumab was associated with an increased incidence of conjunctivitis, according to a recent study published in the British...
Tralokinumab, topical corticosteroids combination beneficial in Atopic dermatitis Dr. Nandita Mohan9 Nov 2021 5:41 PM ISTAtopic dermatitis (AD), is a common chronic or recurrent inflammatory skin disease and affects 15-20% of children and 1-3% of adults worldwide....
Medical Bulletin 8/ November /2021 Dr. Nandita Mohan9 Nov 2021 11:53 AM ISTHere are Top Medical Stories of the dayTralokinumab, corticosteroids helpful in ADAtopic dermatitis (AD), is a common chronic or recurrent...
Tralokinumab plus topical corticosteroids effective in severe atopic dermatitis MD Editorial Team8 Nov 2021 9:00 AM ISTAtopic dermatitis (AD), is a common chronic or recurrent inflammatory skin disease and affects 15-20% of children and 1-3% of adults worldwide. ...
Dupilumab use in Severe Atopic Dermatitis may induce two types of Ocular Surface Diseases Dr. Shravani Dali30 Oct 2021 9:00 AM ISTTwo types of Ocular Surface Diseases were found induced by Dupilumab in Severe Atopic Dermatitis, according to a study published in the Ophthalmology...
Topical JAK and PDE4 inhibitors promising treatments for Atopic dermatitis: Study MD Editorial Team22 Oct 2021 9:00 AM ISTChina: Topical Janus kinase (JAK) and phosphodiesterase-4 (PDE4) inhibitors are novel treatment approaches for atopic dermatitis (AD).A new study...
Pfizer Abrocitinib for atopic dermatitis approved in Japan Ruchika Sharma3 Oct 2021 9:00 AM ISTNew York: Pfizer Inc. has recently announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved...
